Clinical Trial Update: Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma [Phase 2]

View source ↗

Summary

Phase 2 trial by the Children's Oncology Group evaluated irinotecan and temozolomide in young patients with recurrent neuroblastoma; results were posted after c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• Irinotecan (Irinotecan)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Children's Oncology Group | Conditions: Neuroblastoma | Phase 2 | Status: COMPLETED | Results posted: 2014-01-16